Related by context. All words. (Click for frequent words.) 77 Premarket Approval PMA 77 Marketing Approval PMA 69 PMA submission 69 Investigational Device Exemption 68 Premarket Approval Application 66 Premarket Approval 66 Augment Bone Graft 66 Investigational Device Exemption IDE 66 liver resection surgeries 65 Marketing Authorization Application 64 Marketing Authorization Application MAA 64 Marketing Authorisation Application 64 exemption IDE 64 IND Investigational New 63 Augment Injectable 63 Humanitarian Device Exemption 63 Biologic License Application BLA 63 TAXUS Element Stent System 63 Biologics License Application BLA 62 Pivotal Trial 62 PMA Supplement 62 OrCel R 61 Biologics License Application 61 CryoSeal FS System 61 k Premarket Notification 61 application sNDA 60 granted Ortec 60 IDE Investigational Device Exemption 60 Computed Tomography Laser Mammography 60 T Pred 60 MelaFind ® 60 Biological License Application 60 Alair System 60 MelaFind R 60 Premarket Notification 60 IND submission 60 Application BLA 60 Levoleucovorin 60 Omigard 60 Vascular Closure Device 60 Pivotal Clinical Trial 60 Augment ™ Bone Graft 60 Augment ™ 59 Marketing Authorisation Application MAA 59 FDA Accepts 59 BLOOM DM 59 Orathecin 59 Drug Submission 59 proprietary transdermal patch 59 rolling Biologics License 59 Contrave NDA 59 New Drug Application 59 Drug Eluting Stent System 59 Liberte TM 59 BLA filing 59 ULTRASE 59 vertebral augmentation 59 Complete Response 59 Soliris eculizumab 59 Emezine 59 Cellulaze 59 sumatriptan DosePro 59 Dyloject TM 59 fluvoxamine maleate 59 FDA Approvable Letter 59 vapreotide acetate 59 TFAS TM 58 Cellegesic 58 Neovasc Reducer 58 TAXUS Element Paclitaxel Eluting 58 BRILINTA 58 Adhesion Barrier 58 VALSTAR 58 iChem VELOCITY 58 REPEL CV 58 treat atrial flutter 58 BLA submission 58 Trobalt 58 acyclovir Lauriad ® 58 CORTOSS 58 topically applied SEPA 58 Pivotal Phase III 58 Européenne Mark 58 BioSTAR ® 58 eSVS MESH 58 CIP TRAMADOL ER 58 Investigational 58 PROMUS Element Stent 58 Iluvien TM 58 OmniWave 58 AneuRx 58 Biologic License Application 58 INTELLITEMP ® 58 Ventricular Assist System 58 FDA Investigational Device 58 sBLA 58 IV acetaminophen 58 PrevOnco 57 pioglitazone HCl 57 OrCel ® 57 k clearance 57 urethral bulking agent 57 PROGENSA R 57 sNDA submission 57 Submits Supplemental 57 HeartWare System 57 Surgical Adhesive 57 Sonolith i move 57 FDA approvable letter 57 TM Drug Eluting 57 OLpur TM H2H 57 Augment TM 57 FDA Approval 57 supplemental biologics 57 acyclovir Lauriad R 57 drug eluting coronary stent 57 ACUROX 57 Iluvien ® 57 Endeavor Drug Eluting 57 Fibrin Sealant 57 miconazole Lauriad R 57 Marketing Authorization 57 sitagliptin phosphate 57 Metformin GR 57 k premarket 57 Divalproex Sodium 57 Phase III Clinical Trial 57 Frova ® 57 Shonin approval 57 Application MAA 57 TAXUS TM 57 nasal calcitonin product 57 Ketotransdel 57 intravenous acetaminophen 57 ALGRX 56 Clinical Trial Application 56 Metricath Gemini 56 FIRAZYR 56 Valtropin 56 NDA Submission 56 OsseoFix 56 sNDA 56 received CE Conformite 56 Vascular Wrap TM 56 GTC recombinant form 56 post operative ileus 56 Files Investigational 56 PROMUS Element 56 Keppra XR 56 IONSYS TM 56 oxymorphone ER 56 balsalazide tablet 56 PFO migraine 56 BioSTAR R 56 Accelerated Partial Breast Irradiation 56 including eniluracil ADH 56 Bone Graft 56 CryoSeal 56 hoFH 56 Kynapid 56 Anturol TM 56 Approval Supplement 56 Voraxaze 56 CoreValve System 56 ATPace TM 56 Oral Calcitonin 56 buccal tablet 56 Vicinium TM 56 LightTouch TM 56 ADVANCE PD 56 oral transmucosal 56 MIST II 56 Junovan 56 MKC# MKC# PP 56 Expedited Review 56 PROMUS Element Stent System 56 Ozurdex 56 ENTEREG ® 56 Luveniq 56 visit www.dobimedical.com 56 licenses bioactive coatings 56 PureGraft 56 Files IND 56 Cleviprex TM clevidipine 56 Abstral ® 56 Exemption IDE approval 56 hylan GF 56 Orapred ODT 56 herpetic keratitis 56 Roflumilast 55 enoxaparin sodium injection 55 treat chronic sinusitis 55 assigned PDUFA 55 Microcutter 55 pivotal bioequivalence 55 Bazedoxifene 55 PREOS R 55 SOLTAMOX TM tamoxifen citrate 55 RX ACCULINK 55 Kamada AAT 55 ibuprofen Injection 55 SUMAVEL 55 OvaDx 55 Vasomedical enhanced 55 Announces Tentative Approval 55 Nebido 55 PrevOnco ™ 55 Oracea TM 55 Serostim ® 55 alvimopan 55 coronary carotid 55 miconazole Lauriad ® 55 Drug Application 55 Supplemental Biologics License Application 55 PROSTASCINT R 55 Cimzia TM 55 PROVENGE ® 55 ANCHOR trial 55 Aldara ® 55 Lymphoseek ® 55 Romiplostim 55 Initiates Enrollment 55 pen injector 55 testosterone gel LibiGel 55 Marketing Authorisation 55 molecular imaging radiopharmaceutical 55 severe hypercholesterolemia 55 OMAPRO ™ 55 PROMACTA ® 55 PrandiMet 55 Vitrasert R 55 Orphan Drug status 55 lexidronam injection 55 Octreolin 55 ExAblate R 55 VIVITROL ® 55 MicroThermX 55 CLIA waiver 55 Taxus Liberte 55 Intermezzo ® NDA 55 sublingual tablets 55 MONOVISC 55 APF# NDA 55 VISICOL R 55 NUEDEXTA ™ 55 novel oral anticoagulant 55 Phase #b/#a clinical 55 cyclobenzaprine hydrochloride extended 55 FACTIVE R gemifloxacin 55 pancrelipase 55 IND Filing 55 Ereska 55 Optical Biopsy System 55 XIENCE TM 55 Liprotamase 55 supplemental Biologics License Application 55 Submits NDA 55 orally disintegrating 55 FDA Clearance 55 TriActiv 55 TachoSil 55 STEDESA 55 Ranexa R 54 INKP 54 LightTouch 54 Completes Patient Enrollment 54 Submits Response 54 phase IIb trial 54 ORBIT II 54 vitro dissolution 54 highly purified pasteurized 54 alogliptin 54 Phase Ib study 54 vinorelbine emulsion 54 ferumoxytol Injection 54 SpideRX 54 CE Marked 54 ILUVIEN ® 54 Isolator Synergy TM 54 Focalin XR R 54 Oxiplex 54 Biologics Licensing 54 postherpetic neuralgia PHN 54 ARCOXIA 54 GEM #S 54 Nivestim 54 methylnaltrexone bromide 54 Retacrit 54 AFRS TM 54 OLpur TM MD 54 intravesical infusion therapy 54 sNDAs 54 delivers fluocinolone acetonide FA 54 Indomethacin 54 Vernakalant 54 corticotropin injection 54 CLIRS trial 54 SYCREST 54 LymphoStat B TM 54 ONGLYZA ™ 54 generation purine nucleoside 54 Phase IIIb study 54 Loceryl ® 54 TRANSDUR ® 54 rALLy clinical trial 54 GENERIC SILDENAFIL SOFT Generic 54 Saforis 54 Pivotal Study 54 iloprost Inhalation Solution 54 naproxen esomeprazole magnesium 54 Zenvia ™ 54 USFDA approval 54 Absorbable 54 Civacir 54 Morphine Sulfate 54 Dupuytren Contracture 54 Dose Ranging Study 54 LEVADEX TM 54 systemic immunosuppressive drugs 54 Linjeta TM 54 faropenem medoxomil 54 IND Application 54 Besivance 54 Clinical Study Shows 54 BRIM2 54 MitraClip R 54 submit Biologics License 54 investigational 54 pseudobulbar affect PBA 54 NEBIDO R 54 opioid induced bowel dysfunction 54 IND CTA 54 Tengion Neo Bladder Augment 54 Maleate 54 Extended Release Capsules 54 Zingo TM 54 Mutual Recognition Procedure 54 Completes Enrollment 54 octreotide implant 54 ACUROX ® 54 Impax ANDA 54 ThromCat 54 ZEGERID Chewable Tablets 54 Mepact 54 CryoCor Cardiac Cryoablation System 54 ELADUR ™ 54 Alvesco R 54 investigational pharmacologically unique 54 catheter occlusion 54 TLK# 54 Acetavance TM 54 Panzem R 54 VIAject R 54 novel histone deacetylase 54 Mycophenolate Mofetil 54 Targretin capsules 54 Codeine Phosphate 54 Fast Track Designation 54 Triage Stroke Panel 54 Sanvar R 54 balsalazide disodium 54 Tiazac 54 Zelrix 54 oral ridaforolimus 54 k Clearance 54 V Everolimus Eluting Coronary 54 topical diclofenac 54 HP Acthar Gel repository 54 Entereg TM 54 lorcaserin NDA 54 Exocrine Pancreatic Insufficiency 54 Orazol 54 Loxapine 54 candidate XP# 54 sumatriptan injection 54 ANDA containing 54 phase IIb clinical 54 Receives Approvable Letter 54 index assay IVDMIA 54 JZP 54 LEUKINE 54 Phase IIa trials 54 mesylate tablets approved 54 CIP Fenofibrate 54 Receives CE Marking 54 RANK Ligand inhibitor 54 pancreatic insufficiency 54 overactive bladder AA# 54 premarket notification 54 drug eluting stent DES 54 Accelerated Assessment 54 OMNARIS HFA 53 rALLy 53 investigational pan BCR 53 sNDA filing 53 Accelerated Approval 53 BioGlue Surgical Adhesive 53 BioGlue ® 53 vinorelbine tartrate 53 DC Bead 53 Ranolazine 53 treat male hypogonadism 53 Juvederm XC 53 Cardiac Cryoablation System 53 lucinactant 53 BEMA TM Fentanyl 53 FDA Approvals 53 successfully commercialize Iluvien 53 Phase IIb clinical trials 53 submitted supplemental Biologics 53 Personalized Immunotherapy 53 LensAR Laser System 53 Expanded Indication 53 Bupropion HCl ER 53 ISO Vorin TM 53 SUPPRELIN R LA 53 Glycopyrrolate 53 Clinical Study 53 oral rivaroxaban 53 Neuromodulation System 53 injectable gel 53 RSR# 53 Barr ANDA 53 Xibrom TM 53 Orphan Drug Status 53 Afinitor everolimus 53 granisetron hydrochloride 53 TRANSDUR ™ 53 QNEXA ® 53 DORIBAX 53 investigational antiplatelet agent 53 Metformin HCl 53 Approvable letter 53 PillCam Colon 53 memantine HCl 53 TQT study 53 inhaled formulation 53 Urocortin 2 53 Phase III Clinical Trials 53 Elagolix 53 markets HP Acthar 53 Lauriad ® 53 gastrointestinal disorders characterized 53 Zytiga 53 EvaMist TM 53 topical gel formulation 53 Empatic TM 53 sevelamer carbonate 53 HepaGam B 53 Ondansetron Injection USP 53 RIGScan ™ 53 Mylan Receives Approval 53 Release Capsules 53 ALVESCO R 53 Cerepro ® 53 COMFORT II 53 therefore therapeutically equivalent 53 Polymer Microspheres 53 CRMD# 53 Prospective Randomized 53 Opterone R 53 phase IIa clinical 53 BRIM3 53 LUNESTA TM 53 IL# PE#QQR 53 Investigational Oral 53 CERVARIX R 53 OSMOPREP 53 sufentanil 53 hyaluronidase enzyme 53 NeuroFlo 53 neuromodulation therapy 53 Symphony tCGM System 53 FOSAMAX PLUS D 53 Clinical Trial Evaluating 53 indiplon capsules 53 ELIQUIS 53 PDUFA Prescription Drug 53 Fibrin Pad 53 REPRONEX R menotropins 53 Preos 53 pediatric rehydration 53 Orphan Status 53 Solzira TM 53 Phase III pivotal 53 eCTD format 53 RYZOLT 53 CINTREDEKIN BESUDOTOX 53 include Phenoptin TM 53 Biomerix Corporation 53 Resubmission 53 diarrhea predominant irritable 53 telavancin NDA 53 Reloxin ® 53 Eluting Coronary Stent System 53 topical non steroidal 53 Methylnaltrexone 53 prescription laxative 53 topically administered 53 Zenvia Phase III 53 treat lupus renal 53 zileuton CR 53 Aloxi Injection 53 FOLOTYN ® 53 Fast Track Status 53 Submits Investigational 53 candidate deforolimus 53 BYETTA ® 53 PERLANE 53 PDUFA Date 53 JOULFERON 53 Onrigin 53 Rapaflo 53 XOMA 3AB 53 Esbriet pirfenidone 53 Safe GRAS status 53 Exelbine NDA 53 Neo Urinary Conduit 53 Dabigatran etexilate 53 Xcelerant Delivery System 53 Phase IIIb clinical 53 SPL# Gel vaginal microbicide 53 rosuvastatin calcium 53 Cellegesic TM nitroglycerin ointment 53 Menaflex device 53 Qutenza TM 53 Fast Track designation 53 SUCCEED trial 53 intravitreal insert 53 REG1 Anticoagulation System 53 By JAMAAL ABDUL 53 targeted radiotherapeutic 53 candidate NGX 53 GRALISE 53 Lysteda 53 Medtronic CoreValve 53 EVICEL 53 Prodarsan R 53 Oral Spray 53 Zorbtive TM 53 ANDA submission 53 INSPIRE Trial Phase III 53 Vimpat R 53 Zolpimist 53 ATD TM gel 53 Initiate Clinical Trial 53 Regenerative Cells 53 immunotherapeutic agent 53 SinuNase TM 53 SILENOR 53 Marketing Authorization Applications 53 MK #B 53 PD2i Analyzer 53 ruxolitinib 53 SUTENT ® 53 PDX pralatrexate 53 randomized controlled multicenter 53 submitted Biologics License 53 Revo MRI 53 GENTAMICIN SURGICAL IMPLANT 53 PNP inhibitor 53 GRAS notification 53 surgical sealant 53 R bendamustine hydrochloride 53 Phase III clinical trials 53 Testosterone MDTS ® 53 Extina 53 refractory chronic lymphocytic 53 Corlux 53 Dalbavancin 52 phase IIa 52 Delayed Release 52 Stavzor 52 SinuNase ™ 52 BioGlue R 52 GTC recombinant human 52 R lenalidomide 52 oxycodone HCl 52 Entocort 52 Telatinib 52 metformin HCl 52 VITAL Trial 52 Nabi HB Intravenous 52 synthetic lipoglycopeptide antibiotic 52 ACEON R perindopril erbumine 52 Evicel 52 acetonide FA 52 Calcium Acetate 52 Solorel 52 ProUroScan 52 injection USP 52 ATPace 52 Taro Receives 52 PIX# trial 52 Augment Injectable Bone Graft 52 LUVENIQ 52 Ramelteon 52 morphine sulfate extended 52 intravenous iclaprim 52 Ixempra 52 opioid narcotic fentanyl 52 Enjuvia 52 HZT 52 HCl Injection 52 Receives Orphan Drug Designation 52 Onalta ™ 52 NADiA ProsVue 52 Xolegel 52 Decentralized Procedure 52 Phase III randomized controlled 52 Silodosin 52 solifenacin succinate 52 pregabalin Lyrica 52 PDE4 inhibitor 52 Eliquis 52 Synera 52 casopitant 52 Myolimus 52 Novolimus 52 PREVU * POC 52 Glucophage XR 52 novel trazodone formulation 52 Entereg alvimopan 52 Orally Disintegrating Tablets 52 RECOTHROM R 52 Advagraf 52 Lamictal ODT 52 Receives CE 52 Ciclesonide 52 FlexPen 52 XIAFLEX ™ 52 desvenlafaxine 52 Pivotal Phase 52 MAA submission 52 Pre IND 52 VIAject 52 Inhalation Aerosol 52 M Enoxaparin 52 EFAPROXYN 52 bioabsorbable polymer 52 INDs 52 treat opioid induced 52 HFA MDI 52 Brinavess 52 ALTROPANE R 52 vernakalant hydrochloride 52 Durezol TM 52 Phase IIB 52 phase III isavuconazole 52 Exalgo TM 52 CONTAK RENEWAL 52 GLP1 agonist 52 CB2 selective receptor agonist 52 UPLYSO 52 Pliaglis 52 Asclera 52 assessing T DM1 52 submitted Marketing Authorisation 52 Meets Primary Endpoint 52 ZEGERID Capsules 52 personalized cellular immunotherapy 52 Renvela ® 52 Silenor ® doxepin 52 PRIMO CABG 52 BEMA Granisetron 52 Fast Track designations 52 Patient Enrollment 52 Polyphenon ® E 52 OFIRMEV 52 Phase lll 52 docetaxel Taxotere ® 52 Synvisc ONE 52 SURFAXIN 52 Xyzal R 52 severe gastroparesis 52 Transdermal System 52 ISENTRESS raltegravir 52 etanercept Enbrel 52 Soliris TM eculizumab 52 Tarceva TM 52 Trelstar R 52 Phase IIb Trial 52 sapropterin dihydrochloride 52 PD2i Cardiac Analyzer 52 Generx TM 52 CLARITY study 52 SEPET TM 52 FUSILEV ® 52 ATryn ® GTC recombinant 52 NitroMist TM 52 PROVENGE sipuleucel T 52 EOquin TM 52 onabotulinumtoxinA 52 LUVOX CR 52 Phase IIIb 52 SANVAR 52 Ofirmev 52 Diabetic Macular Edema 52 Cefazolin 52 Theratechnologies submitted 52 exocrine pancreatic insufficiency EPI 52 Junovan TM 52 Kuvan TM sapropterin 52 Visicol 52 Rescula 52 HepaMate 52 peripheral vascular stent 52 Thrombin 52 Aerosurf 52 Vascugel 52 MEND CABG 52 myelodysplastic myeloproliferative diseases 52 injectable formulations 52 Phase Ib IIa 52 Phase IIa trial 52 trastuzumab DM1 T DM1 52 Focalin XR ® 52 SonoPrep 52 aripiprazole Abilify 52 SEASONIQUE 52 granulated mesalamine 52 diclofenac sodium 52 Tyvaso 52 QNEXA 52 OvaRex ® MAb 52 Aryplase 52 Clevudine 52 XIENCE PRIME 52 Ampligen r 52 IONSYS 52 Biophan patent 52 DermTech International 52 Australian Therapeutic Goods 52 Impax generic 52 esomeprazole magnesium 52 cutaneous T 52 Loramyc R 52 OMNARIS Nasal Spray 52 DNAwithPap TM Test 52 Phase IIb III 52 Raptiva R 52 Phase 2a clinical 52 Oxytrol R 52 TKB# 52 Dementia Related Psychosis 52 Azathioprine 52 SNT MC# 52 ENLIGHT 52 ORTHOVISC mini 52 IIb clinical trial 52 R vancomycin hydrochloride 52 Generx ™ 52 adenosine injection 52 injectable ibuprofen 52 thrombolytic agent 52 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 52 HuMax TAC 52 intranasal formulation 52 Xenazine ® 52 Genzyme Synvisc 52 METOZOLV ODT 52 5 HT3 antagonist 52 Resten NG 52 IMPELLA R 52 Genasense ® oblimersen 52 Dacogen injection 52 CE Marking 52 dihydrochloride 52 Anturol ® 52 BrachySil TM 52 xanthine oxidase inhibitor 52 Methylin 52 orphan designation 52 mTOR inhibitor 52 Fodosine 52 Zegerid OTC 52 Rhucin ® 52 Keppra ® XR 52 NeuroSTAT ® 52 ONSOLIS TM 52 ReCell 52 Monovisc 52 selective A2A adenosine receptor 51 Certican 51 Pexeva 51 Ceragenin ™ technology 51 Gamunex C 51 orally disintegrating tablets 51 Cloretazine ® 51 Trofex 51 cerebral oximeter available 51 collagen meniscus implant 51 APEX PD 51 HepeX B TM 51 Ablation Frontiers 51 Dexilant 51 peripherally acting 51 MAGE A3 ASCI 51 Eloxatin ® 51 ANDA applicant 51 PEGINTRON TM 51 Fluconazole 51 Therapik R 51 icatibant 51 branded Rectogesic 51 liprotamase 51 Cardium Therapeutics TM 51 RELISTOR ® 51 GAMMAGARD 51 postoperative ileus POI 51 PRISTIQ 51 laromustine 51 ALN HPN 51 Q#IR 51 CIP ISOTRETINOIN 51 POSIDUR TM ELADUR TM 51 fallopian tube cancers 51 OraTest 51 direct renin inhibitor 51 Cordis Cypher 51 Mylan ANDA 51 investigational humanized monoclonal antibody 51 dorzolamide 51 buccal insulin spray 51 Preotact 51 TELINTRA R 51 pancreatic enzyme replacement 51 REVIVE Diabetes 51 Pafuramidine 51 Efficacy Results 51 lorcaserin Phase 51 Febuxostat 51 HepaGam B TM 51 bovine thrombin 51 EP #R 51 Esomeprazole 51 Icatibant 51 human C1 inhibitor 51 Launches Generic Version 51 Submits Biologics License Application 51 targeted antifolate 51 tiapamil 51 ocular formulation 51 tacrolimus capsules 51 Stedesa 51 Pirfenidone 51 ORENCIA ® 51 histamine dihydrochloride 51 Tibotec Therapeutics division 51 Argatroban 51 NDA submission 51 granisetron formulated 51 received CE Marking 51 candidate AP# 51 PD2i Analyzer TM 51 budesonide foam 51 Prochymal TM 51 Complete Response letter 51 Novartis AG Galvus 51 License Application sBLA 51 ENDEAVOR IV 51 mild vasodilator 51 reslizumab 51 Pulsys 51 NPS NPS Pharmaceuticals 51 IMPACT IMmunotherapy 51 zolpidem tartrate sublingual tablet 51 Phase 2b study 51 Study Evaluating 51 sBLA filings 51 LibiGel NDA 51 Drug Submission NDS 51 PLK1 SNALP 51 Losartan Potassium 51 cSSTI 51 Oral BDP 51 Hexvix 51 oral methylnaltrexone 51 Gel repository corticotropin injection 51 include Alferon N 51 paliperidone palmitate 51 Telavancin 51 intravenous AAT 51 rasagiline tablets 51 Known generically 51 Oxycyte ® 51 Melody Transcatheter Pulmonary Valve 51 NDA resubmission 51 Wound Dressing 51 sorafenib tablets 51 Mago ® 51 Viviant 51 Novartis Galvus 51 erlotinib Tarceva ® 51 Phase 1a clinical 51 Altropane 51 ENRICH trial 51 Amyvid 51 Plicera 51 CIMZIA r 51 Pruvel 51 ZoMaxx 51 Fortical R 51 mometasone furoate 51 lintuzumab SGN 51 Tesamorelin 51 PerClot 51 motexafin gadolinium Injection 51 DASISION 51 New Drug IND 51 EchoCRT 51 oral dual endothelin 51 PHASE III 51 Nasdaq PGNX today 51 Safe GRAS 51 IMA# 51 Retisert TM 51 LHRH antagonist 51 Bioral ® 51 thorough QT 51 Market Authorization Application 51 autologous cellular immunotherapy 51 IRX 2 51 thrombin component 51 Proellex TM 51 rALLy trial 51 Simulect 51 dasatinib Sprycel ® 51 carcinogenicity studies 51 Taclonex Scalp R 51 TEMODAL 51 generic Lovenox 51 implantable VeriChip TM 51 catheter occlusion CO 51 human antithrombin 51 POSIDUR TM 51 Somatuline R Autogel R 51 Velaglucerase Alfa 51 Perflubutane Polymer Microspheres 51 Soriatane R 51 Excellagen 51 GLP1 INT TM 51 Ophena TM 51 CHMP recommendation 51 Taclonex R 51 Generic Version 51 Risperidone Oral Solution 51 NitroMist 51 SEASONALE 51 PREOS 51 diagnostic molecular imaging 51 topical gel 51 Carbidopa Levodopa 51 Glybera R 51 Keppra ® levetiracetam 51 Requip XL 51 dalbavancin 51 Desvenlafaxine Succinate 51 containing granisetron 51 interferon gamma 1b 51 DU #b 51 phase IIb study 51 PREGNANT Study 51 pain palliation 51 Paragraph IV certifications 51 European Sepsis Trial 51 Receives Tentative Approval 51 Pegloticase 51 Filgrastim 51 MICARDIS 51 Clinical Trial Results 51 Abstral 51 ethinyl estradiol tablets 51 Nitoman 51 Phase III Pivotal 51 Etravirine 51 Topotecan 51 Phase #b/#a trial 51 ANDA Filing 51 oxypurinol 51 Evamist TM 51 gets USFDA nod 51 Mometasone Furoate 51 Arzerra TM 51 Emezine R 51 Injectable Bone Graft 51 Crofelemer budesonide foam 51 CVBT #B 51 Xcytrin R 51 postapproval 51 Tostrex 51 PULMICORT 51 cetrorelix pamoate 51 Combunox 51 Extended Release 51 Certolizumab pegol 51 LidoPAIN SP 51 SFDA approval 51 Treatment IND